Merck Research Laboratories is dedicated to the field of scientific discoveries and new research to establish excellence in the field of science. Established in the year 1891, The Laboratory is one of the leading global pharmaceutical companies known for its excellence in novel research. In terms of net revenue generation and global market capitalization, the company has become the world’s seventh largest pharmaceutical company. Vaccines, First statin, antibacterials, vioxx, mectizann, Fosamax are some of the famous patented products of the company that is being gaining global reputation. In June 2014 Merck announced its acquisition of Idenix Pharmaceuticals for approximately $3.85 billion. Through the years, the researchers of Merck lab are on the way of helping to find new ways to treat and prevent illness. This is more pronounced in terms of discovery of vitamin B1, to the first measles vaccine, to cold remedies and antacids, to the first statins to treat high cholesterol. The scientists of this lab also have initiated the development of many products to improve animal health, including vaccines and antibiotics.
The following is the list of scholars from Merck Research Laboratories who contributed and/or serves as editors for one or more OMICS International journals and conferences
The following is the list of articles by scholars from Merck Research Laboratories that are published in OMICS International journals.
The following is the list of proceedings by scholars from Merck Research Laboratories that are published in OMICS International journals and conferences.
Satish Kumar and Suresh Kumar Gahlawat